What laboratory tests and scoring system should be used to assess the severity of cirrhosis in a patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 21, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Laboratory-Based Scoring of Cirrhosis Severity

The Child-Pugh score is the primary laboratory-based tool for scoring cirrhosis severity, incorporating five parameters: total bilirubin, serum albumin, prothrombin time/INR, plus clinical assessments of ascites and hepatic encephalopathy, with scores ranging from 5-15 points that classify patients into prognostic classes A (5-6 points), B (7-9 points), or C (10-15 points). 1, 2

Child-Pugh Score Components and Calculation

The Child-Pugh score uses three objective laboratory values and two clinical parameters, each scored 1-3 points 3, 1:

Laboratory Parameters:

  • Total bilirubin: <2 mg/dL = 1 point; 2-3 mg/dL = 2 points; >3 mg/dL = 3 points 3, 1
  • Serum albumin: >3.5 g/dL = 1 point; 2.8-3.5 g/dL = 2 points; <2.8 g/dL = 3 points 3, 1
  • Prothrombin time/INR: <1.7 or PT <4 seconds prolonged = 1 point; INR 1.7-2.3 or PT 4-6 seconds = 2 points; INR >2.3 or PT >6 seconds = 3 points 3, 1

Clinical Parameters:

  • Hepatic encephalopathy: None = 1 point; Grade 1-2 = 2 points; Grade 3-4 = 3 points 3, 1
  • Ascites: Absent = 1 point; Slight = 2 points; Moderate to severe = 3 points 3, 1

Prognostic Classification

Child-Pugh Class A (5-6 points) indicates 90% 5-year survival, Class B (7-9 points) indicates 80% 5-year survival, and Class C (10-15 points) indicates >33% 1-year mortality. 1, 2

The classification directly guides treatment intensity and eligibility for interventions 3, 2:

  • Class A patients can undergo elective surgery and receive most anticoagulants safely 3, 2
  • Class B patients require cautious medication dosing and careful perioperative assessment 3, 2
  • Class C patients should receive only supportive care, avoid elective surgery, and be evaluated urgently for liver transplantation 2

Complementary Scoring Systems

MELD Score (Model for End-Stage Liver Disease)

The MELD score provides superior short-term mortality prediction using only three objective laboratory values: serum bilirubin, serum creatinine, and INR. 1, 2, 4

The MELD score is calculated as: 3.78×ln[bilirubin mg/dL] + 11.2×ln[INR] + 9.57×ln[creatinine mg/dL] + 6.43 5, 6

MELD score ≥15 is an indication for liver transplantation evaluation. 7, 5

The critical advantage of MELD over Child-Pugh is inclusion of renal function (creatinine), which is an independent mortality predictor not captured by Child-Pugh scoring 2, 4. MELD is the standard for transplant organ allocation in the United States 4, 6.

ALBI Score (Albumin-Bilirubin)

The ALBI score uses only albumin and bilirubin levels, eliminating subjective variables like ascites and encephalopathy 1, 2, 4. This score is particularly useful for predicting post-hepatectomy liver failure and outcomes in stable decompensated cirrhosis 2, 4.

Clinical Application Algorithm

For initial assessment of any cirrhotic patient, obtain these laboratory tests: 1, 2, 4

  1. Total bilirubin
  2. Serum albumin
  3. Prothrombin time/INR
  4. Serum creatinine (for MELD calculation)

Calculate both Child-Pugh and MELD scores at diagnosis and every 6 months during follow-up. 7, 5

Use Child-Pugh classification to guide treatment decisions (medication dosing, procedural eligibility, bleeding risk stratification) 3, 2

Use MELD score for transplant evaluation and short-term mortality prediction 2, 4, 7

Critical Pitfalls and Limitations

The Child-Pugh score contains subjective components (ascites and encephalopathy grading) that introduce inter-observer variability. 1, 4

The most significant limitation of Child-Pugh is the absence of renal function assessment, which is a critical prognostic factor. 1, 2 Serum creatinine should always be evaluated alongside Child-Pugh scoring, as renal dysfunction, hyponatremia, and reduced glomerular filtration rate are independent mortality predictors 2.

A 2-point worsening of the Child-Pugh score or progression from Class A to B accurately indicates worsening health status and increased mortality risk. 1

Development of complications such as ascites, variceal bleeding, or hepatorenal syndrome dramatically impacts prognosis, with 5-year survival dropping to 20-50%. 1 The median survival after onset of ascites is only 1.1 years, and after hepatic encephalopathy is 0.92 years 5.

Severe hyponatremia (≤125 mmol/L) is a better mortality predictor than MELD-Na in patients with refractory ascites and should trigger immediate transplant evaluation regardless of Child-Pugh class. 2

Enhanced Prognostic Assessment

Recent evidence suggests that incorporating serum creatinine as a sixth variable in the Child-Pugh score (creating a "modified Child-Pugh score" ranging from 5-19 points) significantly enhances prognostic accuracy, particularly in patients with moderate to severe hepatic encephalopathy 8. This modification showed an area under the curve of 0.852 for predicting complications and survival 8.

References

Guideline

Liver Disease Prognosis Using the Child-Pugh Score

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Managing Sodium Imbalance in Cirrhosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Liver Disease Assessment Using Bilirubin, Albumin, and Prothrombin Time

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Prognostic scores of cirrhosis].

Gastroenterologia y hepatologia, 2008

Research

Liver Disease: Cirrhosis.

FP essentials, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.